You have 9 free searches left this month | for more free features.

Condition

Follicular Lymphoma (2)

Non-Hodgkin Lymphoma (2)

Non Hodgkin Lymphoma (1)

Relapsed Follicular Lymphoma (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Nordic Nanovector (3)

Collaborator

ICON Clinical Research (2)

Intervention

betalutin (2)

betalutin with lilotomab dose 1 (1)

betalutin with lilotomab dose 2 (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

Betalutin

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Non Hodgkin Lymphoma, Follicular Lymphoma, Relapsed Follicular Lymphoma Trial in Ostrava-, Oslo (Betalutin)

Completed

Non Hodgkin Lymphoma
+2 more

Betalutin

Ostrava-, Porubá, Czechia
+1 more

Sep 30, 2022

Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Worldwide (Betalutin)

Active, not recruiting

Non-Hodgkin Lymphoma
Follicular Lymphoma

Betalutin

Little Rock, Arkansas
+95 more

Sep 9, 2022

Non-Hodgkin Lymphoma Trial in Würzburg (Betalutin with lilotomab dose 1, Betalutin with lilotomab dose 2)

Withdrawn

Non-Hodgkin Lymphoma

Betalutin with lilotomab dose 1
Betalutin with lilotomab dose 2

Würzburg, Germany

Universitätsklinikum Würzburg

Jan 8, 2019